SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Contrarian Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: pcyhuang1/5/2007 11:25:32 PM
  Read Replies (1) of 4080
 
MOT -- Contrarian Alert!

Motorola, Inc. (NYSE MOT @$18.94) engages in the design, manufacture, marketing, and sale of mobility products worldwide.

Market Cap (intraday): 45.79B
Enterprise Value (6-Jan-07)3: 39.12B
Trailing P/E (ttm, intraday): 11.29
Forward P/E (fye 31-Dec-07) 1: 12.46
PEG Ratio (5 yr expected): 1.42
Price/Sales (ttm): 1.16
Price/Book (mrq): 2.90
EBITDA (ttm)/Revenue: 8.09
Total Cash (mrq): 14.84B
Total Cash Per Share (mrq): 6.139
Total Debt (mrq): 4.29B
Total Debt/Equity (mrq): 0.25
Current Ratio (mrq): 2.178
Book Value Per Share (mrq): 7.089
Operating Cash Flow (ttm): 4.79B
Levered Free Cash Flow (ttm): 1.17B

Insiders and Institutional Support:

Motorola is a component of 7 publicly traded ETFs and is one of the top 10 holdings in each of the 10 mutual funds' portfolios. Recent insiders' purchases and option awards
range from $20 - $23 per share.

Capitulated Volume:

On Jan. 5, 2007 MOT traded 175,821,500 shares vs. a daily 3-month average of 26,456,400 shares.

Motorola's Profit warning -- online.wsj.com
-- and market arbitrage's pressure on its pending close of the acquisition of Symbol Technology create a wonderful
buying opportunity.

Conclusion:

Value + Insiders and institutional support + capitulated volume = Timely contrarian investment with favorable risk-reward potential.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext